Differential genomic profiling of the progesterone receptor (PR) negative and estrogen receptor (ER) low metastatic breast cancer subtypes through circulating tumor DNA: A TNBC-like disease subtype?

被引:0
|
作者
Gerratana, Lorenzo
Davis, Andrew A.
Foffano, Lorenzo
Reduzzi, Carolina
Podany, Emily L.
Medford, Arielle J.
Clifton, Katherine
Velimirovic, Marko
Putur, Annika
Munoz-Arcos, Laura Sofia
Pontolillo, Letizia
Tapiavala, Shaili
Molteni, Elisabetta
Nicolo, Eleonora
Gradishar, William John
Ma, Cynthia X.
Andreopoulou, Eleni
Puglisi, Fabio
Bardia, Aditya
Cristofanilli, Massimo
机构
[1] Univ Udine, Dept Med DMED, Aviano, Italy
[2] Washington Univ St Louis, St Louis, MO USA
[3] Univ Udine, Udine, Italy
[4] Weill Cornell Med, New York, NY USA
[5] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
[6] Washington Univ, Sch Med, St Louis, MO USA
[7] Cleveland Clin, Cleveland, OH USA
[8] Massachusetts Gen Hosp, Boston, MA USA
[9] Northwestern Univ, Div Hematol & Oncol, Dept Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA
[10] Univ Udine, Dept Med DAME, Udine, Italy
[11] Ctr Riferimento Oncol Aviano CRO, Dipartimento Oncol Medica, IRCCS, Udine, Italy
[12] UCLA Hlth Jonsson Comprehens Canc Ctr, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1039
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Differential genomic profiling of progesterone receptor (PR) negative, estrogen receptor (ER) positive HER2-negative metastatic breast cancer (MBC) through circulating tumor DNA
    Gerratana, Lorenzo
    Davis, Andrew
    Medford, Arielle
    Reduzzi, Carolina
    Clifton, Katherine
    Podany, Emily
    Hensing, Whitney
    Velimirovic, Marko
    Shah, Ami N.
    Foffano, Lorenzo
    Arcos, Laura Munoz
    Nicolo, Eleonora
    Dai, Charles S.
    Keenan, Jennifer
    Behdad, Amir
    Wander, Seth
    Gradishar, William
    Ma, Cynthia
    Puglisi, Fabio
    Bardia, Aditya
    Cristofanilli, Massimo
    CANCER RESEARCH, 2024, 84 (09)
  • [2] Characterization of Estrogen Receptor Positive/Progesterone Receptor Negative/(ER plus /PR-) Breast Cancer (BC)
    Shen, Tiansheng
    Guo, Tao
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    LABORATORY INVESTIGATION, 2016, 96 : 72A - 73A
  • [3] Characterization of Estrogen Receptor Negative/Progesterone Receptor Positive/(ER-/PR plus ) Breast Cancer (BC)
    Shen, Tiansheng
    Brandwein-Gensler, Margaret
    Hameed, Omar
    Siegal, Gene
    Wei, Shi
    LABORATORY INVESTIGATION, 2015, 95 : 65A - 65A
  • [4] Characterization of Estrogen Receptor Negative/Progesterone Receptor Positive/(ER-/PR plus ) Breast Cancer (BC)
    Shen, Tiansheng
    Brandwein-Gensler, Margaret
    Hameed, Omar
    Siegal, Gene
    Wei, Shi
    MODERN PATHOLOGY, 2015, 28 : 65A - 65A
  • [5] Characterization of Estrogen Receptor Positive/Progesterone Receptor Negative/(ER plus /PR-) Breast Cancer (BC)
    Shen, Tiansheng
    Guo, Tao
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    MODERN PATHOLOGY, 2016, 29 : 72A - 73A
  • [6] Re-Appraisal of Estrogen Receptor Negative/Progesterone Receptor Positive (ER-/PR plus ) Breast Cancer Phenotype: True Subtype or Technical Artefact?
    Foley, Niamh M.
    Coll, J. M.
    Lowery, A. J.
    Hynes, S. O.
    Kerin, M. J.
    Sheehan, M.
    Brodie, C.
    Sweeney, K. J.
    PATHOLOGY & ONCOLOGY RESEARCH, 2018, 24 (04) : 881 - 884
  • [7] Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer
    Chung, J. H.
    Pavlick, D.
    Hartmaier, R.
    Schrock, A. B.
    Young, L.
    Forcier, B.
    Ye, P.
    Levin, M. K.
    Goldberg, M.
    Burris, H.
    Gay, L. M.
    Hoffman, A. D.
    Stephens, P. J.
    Frampton, G. M.
    Lipson, D. M.
    Nguyen, D. M.
    Ganesan, S.
    Park, B. H.
    Vahdat, L. T.
    Leyland-Jones, B.
    Mughal, T. I.
    Pusztai, L.
    O'Shaughnessy, J.
    Miller, V. A.
    Ross, J. S.
    Ali, S. M.
    ANNALS OF ONCOLOGY, 2017, 28 (11) : 2866 - 2873
  • [8] Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients
    Aktas, Bahriye
    Mueller, Volkmar
    Tewes, Mitra
    Zeitz, Julia
    Kasimir-Bauer, Sabine
    Loehberg, Christian R.
    Rack, Brigitte
    Schneeweiss, Andreas
    Fehm, Tanja
    GYNECOLOGIC ONCOLOGY, 2011, 122 (02) : 356 - 360
  • [9] Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic Disease
    Page, Karen
    Martinson, Luke J.
    Fernandez-Garcia, Daniel
    Hills, Allison
    Gleason, Kelly L. T.
    Gray, Molly C.
    Rushton, Amelia J.
    Nteliopoulos, Georgios
    Hastings, Robert K.
    Goddard, Kate
    Ions, Charlotte
    Parmar, Vilas
    Primrose, Lindsay
    Openshaw, Mark R.
    Guttery, David S.
    Palmieri, Carlo
    Ali, Simak
    Stebbing, Justin
    Coombes, R. Charles
    Shaw, Jacqueline A.
    JCO PRECISION ONCOLOGY, 2021, 5 : 1768 - 1776
  • [10] Comparison of estrogen and Progesterone receptor expression on circulating Tumor cells and the Primary tumor in Patients with metastatic Breast cancer.
    Aktas, B.
    Mueller, V.
    Schumacher, K.
    Tewes, M.
    Zeitz, J.
    Kasimir-Bauer, S.
    Rack, B.
    Janni, W.
    Solomayer, E.
    Fehm, T.
    ONKOLOGIE, 2010, 33 : 212 - 212